American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 1.
Walker
Karen
K
Thomson Scientific, 77 Hatton Garden, London, EC1N 8JS, UK. karen.walker@thomson.com
Kibble
Alexandra
A
Shumoogam
Jaya
J
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D035843:Biomedical Research / Q000379:methods / Q000639:trends; D001952:Bridged-Ring Compounds / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000031:analogs & derivatives; D006801:Humans; D015394:Molecular Structure; D009369:Neoplasms / Q000188:drug therapy*; D011355:Prodrugs / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use; D043823:Taxoids / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D001952:Bridged-Ring Compounds; D011355:Prodrugs; D043823:Taxoids; C080625:taxane; D004317:Doxorubicin